Regulatory Wrap episode 71: FDA takes aim at pharma companies' social media activity
Автор: Global Relay
Загружено: 2025-10-02
Просмотров: 17
🚨 The FDA is cracking down on pharma companies' social media activity.
In a single day, the agency issued roughly 100 cease-and-desist letters and thousands of warnings for misleading posts—including influencer ads and a pharma CEO’s personal Instagram story.
This week on Regulatory Wrap, Global Relay content writer Ryan Thaxton explores what this means for life sciences organizations and how compliance teams can safeguard against mounting risks.
#regulatorywrap #compliance #regtech
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: